A better target for B-cell lymphomas: From a library of MAG antagonists to nanomolar CD22 ligands
Tuesday, October 25, 2011 - 04:30
in Health & Medicine
Patients suffering from B-cell lymphomas can be treated with antibodies directed against the B-lymphocyte antigen CD20.